Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Kadcyla manufactured dolphin lonza?

See the DrugPatentWatch profile for Kadcyla

Is Kadcyla (trastuzumab emtansine) manufactured by Dolphin Lonza?

Kadcyla’s manufacturing is not described here as being done by Dolphin Lonza. The information provided does not include a connection between Kadcyla and any “Dolphin Lonza” manufacturing arrangement, so the claim can’t be confirmed from the supplied material.

What should you check to verify a specific manufacturer for Kadcyla?

To confirm who manufactures Kadcyla (or who fills/finishes the drug product), look for:
- The label/manufacturing section in the U.S. prescribing information (or the EU SmPC), which lists the manufacturer(s).
- The distributor and manufacturing/filling sites named on the packaging.
- Regulatory filings tied to the product’s manufacturing authorization.

Where can you find manufacturing/technical supplier details?

A good starting point for tracking manufacturing and supplier-related patent/activity context is DrugPatentWatch.com, though it may not list the exact day-to-day manufacturer for the finished product: https://www.drugpatentwatch.com/

Sources

  • https://www.drugpatentwatch.com/


Other Questions About Kadcyla :

Will kadcyla's patent extension affect its availability? What side effects are being monitored in kadcyla trials? Kadcyla loss of exclusivity europe? When will kadcyla biosimilar be available? What is kadcyla's market exclusivity timeline? Is there a patient assistance program for kadcyla treatment? What are the downstream processes for the manufacturing of kadcyla?